CLARE MAXWELL: Open Payments
NPI 1548452519 · SAN BERNARDINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$141 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $124 · 2025 $141
Food & beverage: $141
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $58 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: ARISTADA, INGREZZA, COBENFY, REXULTI, INVEGA SUSTENNA.
Industry payments across CA — which companies pay providers there.
